Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00336310
Status:
UNKNOWN
Last Update Posted:
2006-06-13
First Post:
2006-06-12
Brief Title:
A Double-Blind Randomized Parallel Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients
Sponsor:
Organization:
National Cheng-Kung University Hospital